Suppr超能文献

rs11200014、rs2981579和rs1219648基因多态性与乳腺癌易感性的关联:一项荟萃分析。

Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis.

作者信息

Zhang Yafei, Lu Hongwei, Ji Hong, Lu Le, Liu Pengdi, Hong Ruofeng, Li Yiming

机构信息

Department of General Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

出版信息

Medicine (Baltimore). 2017 Dec;96(50):e9246. doi: 10.1097/MD.0000000000009246.

Abstract

BACKGROUND

Research on the polymorphism of breast cancer (BC) helps to search the BC susceptibility gene for mass screening, early diagnosis, and gene therapy, which has become a hotspot in BC research field. Previous studies have suggested associations between rs11200014, rs2981579, and rs1219648 polymorphisms and cancer risk. The aim of this study was to evaluate the relationship between rs11200014, rs2981579, and rs1219648 polymorphism and BC risk.

METHODS

PubMed, Web of science, and the Cochrane Library databases were searched before October 11, 2015, to identify relevant studies. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to estimate the strength of associations. Sensitivity and subgroup analyses were conducted. All included cases should have been diagnosed by a pathological examination.

RESULTS

Twenty-six studies published from 2007 to 2015 were included in this meta-analysis. The pooled results showed that there was a significant association between all the 3 variants and BC risk in any genetic model. When stratified by Source of controls, the results showed the same association between rs2981579 polymorphism and BC susceptibility in hospital-based (HB) group, although there was not any genetic model attained statistical correlation in population-based (PB) group. Subgroup analysis was performed on rs1219648 by ethnicity and Source of controls, and the effects remained in Asians, Caucasians, HB, and PB groups.

CONCLUSION

This meta-analysis of case-control studies provides strong evidence that fibroblast growth factor 2 (FGFR2; rs11200014, rs2981579, and rs1219648) polymorphisms are significantly associated with the BC risk. For rs2981579, the association remained in hospital populations, while not in general populations. For rs1219648, the association remained in Asians, Caucasians, hospital populations, and general populations. However, further large-scale multicenter epidemiological studies are warranted to confirm this finding and the molecular mechanism for the associations need to be elucidated in future studies.

摘要

背景

乳腺癌(BC)的多态性研究有助于寻找BC易感基因,以进行大规模筛查、早期诊断和基因治疗,这已成为BC研究领域的一个热点。先前的研究表明rs11200014、rs2981579和rs1219648多态性与癌症风险之间存在关联。本研究的目的是评估rs11200014、rs2981579和rs1219648多态性与BC风险之间的关系。

方法

检索2015年10月11日前的PubMed、Web of science和Cochrane图书馆数据库,以识别相关研究。采用比值比(OR)和95%置信区间(CI)来估计关联强度。进行了敏感性和亚组分析。所有纳入的病例均应通过病理检查确诊。

结果

本荟萃分析纳入了2007年至2015年发表的26项研究。汇总结果显示,在任何遗传模型中,所有这3个变异与BC风险之间均存在显著关联。按对照来源分层时,结果显示在基于医院(HB)的组中,rs2981579多态性与BC易感性之间存在相同的关联,尽管在基于人群(PB)的组中没有任何遗传模型达到统计学相关性。按种族和对照来源对rs1219648进行亚组分析,在亚洲人、白种人、HB组和PB组中效应仍然存在。

结论

这项病例对照研究的荟萃分析提供了有力证据,表明成纤维细胞生长因子2(FGFR2;rs11200014、rs2981579和rs1219648)多态性与BC风险显著相关。对于rs2981579,这种关联在医院人群中仍然存在,而在一般人群中不存在。对于rs1219648,这种关联在亚洲人、白种人、医院人群和一般人群中仍然存在。然而,需要进一步开展大规模多中心流行病学研究来证实这一发现,并且在未来的研究中需要阐明这些关联的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc61/5815769/165a2c835262/medi-96-e9246-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验